{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:14:10Z","timestamp":1770790450807,"version":"3.50.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R21 CA185811"],"award-info":[{"award-number":["R21 CA185811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Family and Preventive Medicine at the University of Utah and the NCRR"},{"name":"Sharing Statewide Health Data for Genetic Research","award":["R01 RR021746"],"award-info":[{"award-number":["R01 RR021746"]}]},{"name":"Utah State Department of Health and the University of Utah"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Breast cancer is the leading cause of cancer death among Hispanic women. The aim of our study was to estimate cardiovascular disease (CVD) risk among Hispanic and non-Hispanic White (NHW) breast cancer survivors compared with their respective general population cohorts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cohorts of 17 469 breast cancer survivors (1774 Hispanic and 15 695 NHW) in the Utah Cancer Registry diagnosed between 1997 and 2016, and 65 866 women (6209 Hispanic and 59 657 NHW) from the general population in the Utah Population Database were identified. Cox proportional hazards models were used to estimate hazard ratios (HRs) for CVD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The risk of diseases of the circulatory system was higher in Hispanic than NHW breast cancer survivors 1-5\u2009years after cancer diagnosis, in comparison with their respective general population cohorts (HRHispanic = 1.94, 99% confidence interval [CI] = 1.49 to 2.53; HNHW = 1.38, 99% CI\u2009=\u20091.33 to 1.43; 2-sided Pheterogeneity = .01, respectively). Increased risks were observed for both Hispanic and NHW breast cancer survivors for diseases of the heart and the veins and lymphatics, compared with the general population cohorts. More than 5\u2009years after cancer diagnosis, elevated risk of diseases of the veins and lymphatics persisted in both ethnicities. The CVD risk due to chemotherapy and hormone therapy was higher in Hispanic than NHW breast cancer survivors but did not differ for distant stage, higher baseline comorbidities, or baseline smoking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We observed a risk difference for diseases of the circulatory system between Hispanic and NHW breast cancer survivors compared with their respective general population cohorts but only within the first 5\u2009years of cancer diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jncics\/pkab016","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T21:19:51Z","timestamp":1613078391000},"source":"Crossref","is-referenced-by-count":13,"title":["Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort"],"prefix":"10.1093","volume":"5","author":[{"given":"Qingqing","family":"Hu","sequence":"first","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"},{"name":"Huntsman Cancer Institute, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-997X","authenticated-orcid":false,"given":"Chun-Pin","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"},{"name":"Huntsman Cancer Institute, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-9819","authenticated-orcid":false,"given":"Kerry","family":"Rowe","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Snyder","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikrant","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"University of Utah Health Sciences Center, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-6058","authenticated-orcid":false,"given":"Michael","family":"Newman","sequence":"additional","affiliation":[{"name":"University of Utah Health Sciences Center, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-698X","authenticated-orcid":false,"given":"Alison","family":"Fraser","sequence":"additional","affiliation":[{"name":"Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Smith","sequence":"additional","affiliation":[{"name":"Pedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-3292","authenticated-orcid":false,"given":"Lisa H","family":"Gren","sequence":"additional","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-2917","authenticated-orcid":false,"given":"Christina","family":"Porucznik","sequence":"additional","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9932-3947","authenticated-orcid":false,"given":"Joseph B","family":"Stanford","sequence":"additional","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gaffney","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Salt Lake City, UT, USA"},{"name":"Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-5930","authenticated-orcid":false,"given":"N Lynn","family":"Henry","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivette","family":"Lopez","sequence":"additional","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-2049","authenticated-orcid":false,"given":"Mia","family":"Hashibe","sequence":"additional","affiliation":[{"name":"Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"},{"name":"Huntsman Cancer Institute, Salt Lake City, UT, USA"},{"name":"Utah Cancer Registry, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"2021041713560084300_pkab016-B1","volume-title":"Cancer Treatment & Survivorship Facts & Figures 2019-2021","author":"American Cancer Society","year":"2019"},{"key":"2021041713560084300_pkab016-B2","volume-title":"Cancer Facts & Figures for Hispanics\/Latinos 2018-2020","author":"American Cancer Society","year":"2018"},{"key":"2021041713560084300_pkab016-B3","volume-title":"Cancer Facts & Figures for Hispanics\/Latinos 2015-2017","author":"American Cancer Society","year":"2015"},{"key":"2021041713560084300_pkab016-B4","author":"SEERExplorer"},{"issue":"5","key":"2021041713560084300_pkab016-B5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju055","article-title":"US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status","volume":"106","author":"Howlader","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2021041713560084300_pkab016-B6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10549-010-1191-6","article-title":"Disparities in breast cancer characteristics and outcomes by race\/ethnicity","volume":"127","author":"Ooi","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2021041713560084300_pkab016-B7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-012-2176-4","article-title":"Impact of comorbidity on management and mortality in women diagnosed with breast cancer","volume":"135","author":"Berglund","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2021041713560084300_pkab016-B8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1037\/lat0000055","article-title":"Cancer outcomes in Hispanics\/Latinos in the United States: an integrative review and conceptual model of determinants of health","volume":"4","author":"Yanez","year":"2016","journal-title":"J Lat Psychol"},{"issue":"5","key":"2021041713560084300_pkab016-B9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.amepre.2013.01.016","article-title":"Evidence-based obesity treatment interventions for Latino adults in the U.S.: a systematic review","volume":"44","author":"Perez","year":"2013","journal-title":"Am J Prev Med"},{"issue":"17","key":"2021041713560084300_pkab016-B10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2012.14517","article-title":"Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic\/Latino individuals of diverse backgrounds in the United States","volume":"308","author":"Daviglus","year":"2012","journal-title":"JAMA"},{"issue":"23","key":"2021041713560084300_pkab016-B11","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1002\/cncr.31775","article-title":"Changes in cardiovascular disease risk and risk factors among women with and without breast cancer","volume":"124","author":"Anderson","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"2021041713560084300_pkab016-B12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-016-3810-3","article-title":"Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study","volume":"157","author":"Connor","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2021041713560084300_pkab016-B13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","article-title":"Risk of death from cardiovascular disease following breast cancer: a systematic review","volume":"164","author":"Gernaat","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"2021041713560084300_pkab016-B14","doi-asserted-by":"crossref","first-page":"e0184174","DOI":"10.1371\/journal.pone.0184174","article-title":"Cardiovascular disease and mortality after breast cancer in postmenopausal women: results from the Women\u2019s Health Initiative","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"2021041713560084300_pkab016-B15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1055-9965.EPI-14-1140","article-title":"Diabetes and other comorbidities in breast cancer survival by race\/ethnicity: the California breast cancer survivorship consortium (CBCSC)","volume":"24","author":"Wu","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2021041713560084300_pkab016-B16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00125-012-2793-9","article-title":"Incidence of diabetes among postmenopausal breast cancer survivors","volume":"56","author":"Yun","year":"2013","journal-title":"Diabetologia"},{"issue":"5","key":"2021041713560084300_pkab016-B17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2021041713560084300_pkab016-B18","author":"American Academy of Family Physicians. Coding for tobacco screening and cessation"},{"key":"2021041713560084300_pkab016-B19","author":"Utah Department of Health","year":"2015"},{"key":"2021041713560084300_pkab016-B20","volume-title":"Next Steps for the InterState Exchange of Nonresident Data between State Health Data Organizations","author":"National Association of Health Data Organizations","year":"2009"},{"key":"2021041713560084300_pkab016-B21","author":"US Census Bureau. State-to-State Migration Flows","year":"2018"},{"key":"2021041713560084300_pkab016-B22","author":"Agency for Health Research and Quality","year":"2020"},{"issue":"7414","key":"2021041713560084300_pkab016-B23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"2021041713560084300_pkab016-B24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2005.04.5799","article-title":"Missed opportunities: racial disparities in adjuvant breast cancer treatment","volume":"24","author":"Bickell","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"2021041713560084300_pkab016-B25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.25542","article-title":"The association of race\/ethnicity, insurance status, and socioeconomic factors with breast cancer care","volume":"117","author":"Freedman","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"2021041713560084300_pkab016-B26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-017-4389-z","article-title":"Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women","volume":"166","author":"Martinez","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2021041713560084300_pkab016-B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.163.1.49","article-title":"Differences in breast cancer stage, treatment, and survival by race and ethnicity","volume":"163","author":"Li","year":"2003","journal-title":"Arch Intern Med"},{"issue":"10203","key":"2021041713560084300_pkab016-B28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"2021041713560084300_pkab016-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.puhe.2017.10.005","article-title":"Socio-economic inequalities in the incidence of four common cancers: a population-based registry study","volume":"154","author":"Tweed","year":"2018","journal-title":"Public Health"},{"issue":"1","key":"2021041713560084300_pkab016-B30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2006.07.4393","article-title":"Incidence of venous thromboembolism and the impact on survival in breast cancer patients","volume":"26","author":"Chew","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"2021041713560084300_pkab016-B31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/SAP.0000000000001249","article-title":"Venous thromboembolism after surgical treatment of breast cancer","volume":"80","author":"Momeni","year":"2018","journal-title":"Ann Plas Surg"},{"issue":"8","key":"2021041713560084300_pkab016-B32","first-page":"e30","article-title":"Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association","volume":"137","author":"Mehta","year":"2018","journal-title":"Am Heart Assoc Circ"},{"issue":"4","key":"2021041713560084300_pkab016-B33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","article-title":"Myocarditis","volume":"52","author":"Blauwet","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"2021041713560084300_pkab016-B34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005633","article-title":"Long-term cardiovascular risk after radiotherapy in women with breast cancer","volume":"6","author":"Cheng","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2021041713560084300_pkab016-B35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0360-3016(00)01531-5","article-title":"Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results","volume":"49","author":"Hardenbergh","year":"2001","journal-title":"Int J Radiat Oncol"},{"issue":"11","key":"2021041713560084300_pkab016-B36","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1200\/JCO.1998.16.11.3493","article-title":"Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients","volume":"16","author":"Shapiro","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"2021041713560084300_pkab016-B37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12012-007-0016-2","article-title":"Pathophysiology and diagnosis of cancer drug induced cardiomyopathy","volume":"7","author":"Zuppinger","year":"2007","journal-title":"Cardiovasc Toxicol"},{"issue":"5","key":"2021041713560084300_pkab016-B38","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.STR.0000160748.88374.ce","article-title":"Autonomic function is impaired in elderly stroke survivors","volume":"36","author":"McLaren","year":"2005","journal-title":"Stroke"},{"issue":"6","key":"2021041713560084300_pkab016-B39","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0735-1097(94)90148-1","article-title":"Change of autonomic influence on the heart immediately before the onset of spontaneous idiopathic ventricular tachycardia","volume":"24","author":"Fei","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2021041713560084300_pkab016-B40","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/cphy.c140059","article-title":"Anthracycline-induced cardiomyopathy in adults","volume":"5","author":"Tan","year":"2015","journal-title":"Compr Physiol"},{"issue":"2","key":"2021041713560084300_pkab016-B41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000665","article-title":"Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies","volume":"3","author":"Hahn","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2021041713560084300_pkab016-B42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/annonc\/mdh150","article-title":"Schmiegel W5-fluorouracil induces arterial vasocontractions","volume":"15","author":"S\u00fcdhoff","year":"2004","journal-title":"Ann Oncol"},{"issue":"1","key":"2021041713560084300_pkab016-B43","first-page":"89","article-title":"Paclitaxel-induced cardiotoxicity: an ultrastructural study","volume":"120","author":"Shek","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2021041713560084300_pkab016-B44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40471-016-0083-7","article-title":"Variability in cancer risk and outcomes within US Latinos by national origin and genetic ancestry","volume":"3","author":"Stern","year":"2016","journal-title":"Curr Epidemiol Rep"},{"issue":"5","key":"2021041713560084300_pkab016-B45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/her\/15.5.559","article-title":"Breast cancer screening in regional Hispanic populations","volume":"15","author":"Ramirez","year":"2000","journal-title":"Health Educ Res"},{"issue":"1","key":"2021041713560084300_pkab016-B46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0962280215623107","article-title":"Estimating sample size in the presence of competing risks \u2013cause-specific hazard or cumulative incidence approach?","volume":"27","author":"Tai","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"2021041713560084300_pkab016-B47","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2021041713560084300_pkab016-B48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10549-011-1843-1","article-title":"Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer","volume":"131","author":"Bardia","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2021041713560084300_pkab016-B49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12889-019-6391-3","article-title":"Examining validity of body mass index calculated using height and weight data from the US driver license","volume":"19","author":"Chernenko","year":"2019","journal-title":"BMC Public Health"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkab016\/36255008\/pkab016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncics\/article-pdf\/5\/2\/pkab016\/37119618\/pkab016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncics\/article-pdf\/5\/2\/pkab016\/37119618\/pkab016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T13:56:43Z","timestamp":1618667803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkab016\/6135090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkab016","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,2,15]]},"article-number":"pkab016"}}